Clinical trial
Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis
NCT00152308 · Translumina GmbH, Industry · Terminated
Key facts
| NCT number | NCT00152308 |
|---|---|
| Title | Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis |
| Official title | A Prospective, Placebo-Controlled, Double-Blind, Randomized Study Evaluating the Efficacy of Non-Polymer-Based Coating With Two Different Rapamycin-Dosages for the Prevention of Restenosis After Percutaneous Coronary Interventions |
| Lead sponsor | Translumina GmbH, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Disease |
| Intervention type | Device |
| Interventions | 2% rapamycin-eluting YUKONdes PEARL-stent, 1% rapamycin-eluting YUKONdes PEARL-stent, YUKONdes PEARL-stent coated with placebo (ethanol) |
| Enrollment | 333 |
| Start date | Dec 1, 2004 |
| Completion | Feb 1, 2007 |
| First posted | Sep 9, 2005 |
| Last update posted | Oct 8, 2020 |
| Countries | Austria, Germany, Israel |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: